I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hertzberg, M.
~ 600
results:
Search for persons
X
Format
Online
Print
Mediatypes
Books
Articles (Online)
OpenAccess-fulltext
more...
Map
Bookchapter (Online)
less...
Languages
german (8)
english (522)
more...
finnish (1)
less...
Sorted by: Relevance
Sorted by: Year
?
1
PHASE 1 STUDY OF JNJ‐67856633, A FIRST‐IN‐HUMAN MALT1 INHIB..:
Hertzberg, M.
;
Kalac, M.
;
Cheah, C. Y.
...
Hematological Oncology. 41 (2023) S2 - p. 131-132 , 2023
Link:
https://doi.org/10.1002/..
?
2
BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANC..:
Borchmann, P.
;
Moccia, A. A.
;
Greil, R.
...
Hematological Oncology. 41 (2023) S2 - p. 881-882 , 2023
Link:
https://doi.org/10.1002/..
?
3
Glofitamab plus R‐CHOP or polatuzumab vedotin‐R‐CHP is deli..:
Minson, A.
;
Verner, E.
;
Giri, P.
...
Hematological Oncology. 41 (2023) S2 - p. 421-422 , 2023
Link:
https://doi.org/10.1002/..
?
4
Toxicities at one year follow‐up in patients with advanced ..:
Ferdinandus, J.
;
Moccia, A. A.
;
Greil, R.
...
Hematological Oncology. 41 (2023) S2 - p. 363-364 , 2023
Link:
https://doi.org/10.1002/..
?
5
Subgroup analysis of elderly patients (pts) with diffuse la..:
Hu, B.
;
Reagan, P. M.
;
Sehn, L. H.
...
Hematological Oncology. 41 (2023) S2 - p. 416-418 , 2023
Link:
https://doi.org/10.1002/..
?
6
S220: GLOFITAMAB INDUCES DURABLE COMPLETE REMISSIONS AND HA..:
Dickinson, M.
;
Carlo-Stella, C.
;
Morschhauser, F.
...
HemaSphere. 6 (2022) - p. 121-122 , 2022
Link:
https://doi.org/10.1097/..
?
7
A PHASE III TRIAL OF GLOFITAMAB PLUS GEMCITABINE AND OXALIP..:
Hertzberg, M.
;
Ku, M.
;
Catalani, O.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
8
Sustainable bioenergy for climate mitigation: developing dr..:
Taylor, G
;
Donnison, I S
;
Murphy-Bokern, D
...
Annals of Botany. 124 (2019) 4 - p. 513-520 , 2019
Link:
https://doi.org/10.1093/..
?
9
CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS..:
Lewis, K.L.
;
Dowling, M.
;
Bavishi, K.
...
Hematological Oncology. 37 (2019) S2 - p. 535-537 , 2019
Link:
https://doi.org/10.1002/..
?
10
PCN381 - REFERENCE VALUES FOR EORTC QLQ-C30 IN HODGKIN'S LY..:
Mierzynska, J.
;
Taye, M.
;
Pe, M.
...
Value in Health. 21 (2018) - p. S79 , 2018
Link:
https://doi.org/10.1016/..
?
11
Oral health and dental morbidity in long‐term allogeneic bl..:
Dyer, G
;
Brice, L
;
Schifter, M
...
Australian Dental Journal. 63 (2018) 3 - p. 312-319 , 2018
Link:
https://doi.org/10.1111/..
?
12
An individualised risk-adapted protocol of pre- and post tr..:
Grigg, A
;
Butcher, B
;
Khodr, B
...
Bone Marrow Transplantation. 52 (2017) 9 - p. 1288-1293 , 2017
Link:
https://doi.org/10.1038/..
?
13
IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIO..:
Hiddemann, W.
;
Barbui, A.M.
;
Canales Albendea, M.A.
...
Hematological Oncology. 35 (2017) S2 - p. 117-119 , 2017
Link:
https://doi.org/10.1002/..
?
14
Recent treatment advances in Hodgkin lymphoma: a concise re..:
Arulogun, S.
;
Hertzberg, M.
;
Gandhi, M. K.
Internal Medicine Journal. 46 (2016) 12 - p. 1364-1369 , 2016
Link:
https://doi.org/10.1111/..
?
15
The experience of survival following allogeneic haematopoie..:
Gifford, G
;
Gilroy, N
;
Dyer, G
...
Bone Marrow Transplantation. 51 (2016) 10 - p. 1361-1368 , 2016
Link:
https://doi.org/10.1038/..
1-15